Primary |
Product Used For Unknown Indication |
50.6% |
Borrelia Infection |
4.6% |
Brain Abscess |
4.6% |
Pneumonia |
4.6% |
Lung Abscess |
3.4% |
Neoplasm |
3.4% |
Tooth Infection |
3.4% |
Cholecystitis |
2.3% |
Bipolar Disorder |
2.3% |
Clostridial Infection |
2.3% |
Clostridium Difficile Colitis |
2.3% |
Diverticulitis |
2.3% |
Hepatic Amoebiasis |
2.3% |
Infection |
2.3% |
Pilonidal Cyst |
2.3% |
Wound Infection |
2.3% |
Abdominal Abscess |
1.1% |
Abdominal Infection |
1.1% |
Antibiotic Therapy |
1.1% |
Bacterial Infection |
1.1% |
|
Toxic Encephalopathy |
20.0% |
Neurotoxicity |
7.5% |
Paraesthesia |
7.5% |
Toxicity To Various Agents |
7.5% |
Vomiting |
7.5% |
Diarrhoea |
5.0% |
Encephalopathy |
5.0% |
Hallucination |
5.0% |
Neutropenic Sepsis |
5.0% |
Tongue Discolouration |
5.0% |
Acute Generalised Exanthematous Pustulosis |
2.5% |
Angioedema |
2.5% |
Arthralgia |
2.5% |
Clostridium Difficile Infection |
2.5% |
Clostridium Test Positive |
2.5% |
Deafness Bilateral |
2.5% |
Dizziness |
2.5% |
Drug Interaction |
2.5% |
Electrocardiogram Qt Prolonged |
2.5% |
Electrocardiogram T Wave Inversion |
2.5% |
|
Secondary |
Product Used For Unknown Indication |
38.4% |
Neutropenic Sepsis |
6.8% |
Drug Use For Unknown Indication |
6.8% |
Pneumonia Klebsiella |
6.8% |
Cardiac Failure |
4.1% |
Depression |
4.1% |
Infection |
4.1% |
Intra-abdominal Abscess |
4.1% |
Tooth Abscess |
4.1% |
Tooth Infection |
4.1% |
Analgesic Therapy |
2.7% |
Colonoscopy |
2.7% |
Colitis |
1.4% |
Diarrhea |
1.4% |
Pneumonia |
1.4% |
Appendicitis Perforated |
1.4% |
Clostridium Difficile Infection |
1.4% |
Deep Vein Thrombosis |
1.4% |
Dental Abscess |
1.4% |
Dyslipidaemia |
1.4% |
|
Epilepsy |
8.7% |
Thrombocytopenia |
8.7% |
Vomiting |
8.7% |
Acute Generalised Exanthematous Pustulosis |
4.3% |
Drug Reaction With Eosinophilia And Systemic Symptoms |
4.3% |
Dysphagia |
4.3% |
Lymphadenopathy |
4.3% |
Malaise |
4.3% |
Nausea |
4.3% |
Palpitations |
4.3% |
Pulmonary Fibrosis |
4.3% |
Renal Failure |
4.3% |
Sepsis |
4.3% |
Septic Shock |
4.3% |
Soft Tissue Necrosis |
4.3% |
Transient Ischaemic Attack |
4.3% |
Urine Output Decreased |
4.3% |
Vasculitis |
4.3% |
Ventricular Tachycardia |
4.3% |
White Blood Cell Count Decreased |
4.3% |
|
Concomitant |
Product Used For Unknown Indication |
14.0% |
Pseudomonas Infection |
14.0% |
Waldenstrom's Macroglobulinaemia |
10.5% |
Hypertension |
7.0% |
Haemophilus Infection |
5.3% |
Pancreatic Carcinoma Metastatic |
5.3% |
Plasma Cell Myeloma |
5.3% |
Bone Marrow Failure |
3.5% |
Chronic Lymphocytic Leukaemia |
3.5% |
Chronic Obstructive Pulmonary Disease |
3.5% |
Convulsion Prophylaxis |
3.5% |
Depression |
3.5% |
Mastitis |
3.5% |
Menopausal Symptoms |
3.5% |
Neck Pain |
3.5% |
Pneumonia |
3.5% |
Abdominal Abscess |
1.8% |
Abdominal Infection |
1.8% |
Acromegaly |
1.8% |
Antiemetic Supportive Care |
1.8% |
|
Tremor |
9.7% |
Vomiting |
9.7% |
Panic Attack |
6.5% |
Paraesthesia |
6.5% |
Performance Status Decreased |
6.5% |
Somnolence |
6.5% |
Swollen Tongue |
6.5% |
Virus Serology Test Positive |
6.5% |
White Blood Cell Count Increased |
6.5% |
Blood Calcium Increased |
3.2% |
Breast Cancer |
3.2% |
Cellulitis Staphylococcal |
3.2% |
Cerebrovascular Accident |
3.2% |
Clostridium Difficile Colitis |
3.2% |
Epilepsy |
3.2% |
Hypoaesthesia Oral |
3.2% |
Lung Transplant Rejection |
3.2% |
Mental Status Changes |
3.2% |
Methaemoglobinaemia |
3.2% |
Myalgia |
3.2% |
|